Academic literature on the topic 'Necrotizing enterocolitis, infants, treatment'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Necrotizing enterocolitis, infants, treatment.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Necrotizing enterocolitis, infants, treatment"
Black, Virginia D., Carol M. Rumack, Lula O. Lubchenco, and Beverly L. Koops. "Gastrointestinal Injury in Polycythemic Term Infants." Pediatrics 76, no. 2 (August 1, 1985): 225–31. http://dx.doi.org/10.1542/peds.76.2.225.
Full textBüyüktiryaki, Mehmet, Mehmet Yekta Oncel, Nilufer Okur, Turan Derme, and Serife Suna Oguz. "Necrotizing Enterocolitis after Octreotide Treatment in a Preterm Newborn with Idiopathic Congenital Chylothorax." APSP Journal of Case Reports 8, no. 5 (November 28, 2017): 34. http://dx.doi.org/10.21699/ajcr.v8i5.628.
Full textDe Bernardo, Giuseppe, Desiree Sordino, Carolina De Chiara, Marina Riccitelli, Francesco Esposito, Maurizio Giordano, and Antonino Tramontano. "Management of NEC: Surgical Treatment and Role of Traditional X-ray Versus Ultrasound Imaging, Experience of a Single Centre." Current Pediatric Reviews 15, no. 2 (July 22, 2019): 125–30. http://dx.doi.org/10.2174/1573396314666181102122626.
Full textBhatti, Karandeep S., and Arvinder Singh. "Necrotizing enterocolitis: a case report." International Journal of Contemporary Pediatrics 7, no. 5 (April 24, 2020): 1150. http://dx.doi.org/10.18203/2349-3291.ijcp20201654.
Full textPierro, Agostino, and Nigel Hall. "Surgical treatment of infants with necrotizing enterocolitis." Seminars in Neonatology 8, no. 3 (June 2003): 223–32. http://dx.doi.org/10.1016/s1084-2756(03)00025-3.
Full textCarter, Brigit M. "Treatment Outcomes of Necrotizing Enterocolitis for Preterm Infants." Journal of Obstetric, Gynecologic & Neonatal Nursing 36, no. 4 (July 2007): 377–85. http://dx.doi.org/10.1111/j.1552-6909.2007.00157.x.
Full textKim, L. V., V. A. Zhelev, G. V. Slizovsky, and T. S. Liulka. "Early diagnosis of necrotizing enterocolitis." Voprosy praktičeskoj pediatrii 17, no. 2 (2022): 148–52. http://dx.doi.org/10.20953/1817-7646-2022-2-148-152.
Full textPham, Jennifer T., Allison F. Dahlgren, and Phornphat Rasamimari. "Recommendations for Diagnosis and Prevention of Cytomegalovirus-Associated Necrotizing Enterocolitis in Breast-Fed Preterm Infants." Journal of Pediatric Pharmacology and Therapeutics 27, no. 2 (February 1, 2022): 180–91. http://dx.doi.org/10.5863/1551-6776-27.2.180.
Full textMaltais-Bilodeau, Camille, Ewa Henckel, Kelly D. Cobey, Nadera Ahmadzai, Becky Skidmore, Emanuela Ferretti, and Bernard Thébaud. "Efficacy of mesenchymal stromal cells in preclinical models of necrotizing enterocolitis: a systematic review protocol." F1000Research 10 (October 5, 2021): 1011. http://dx.doi.org/10.12688/f1000research.73094.1.
Full textMaltais-Bilodeau, Camille, Ewa Henckel, Kelly D. Cobey, Nadera Ahmadzai, Becky Skidmore, Emanuela Ferretti, and Bernard Thébaud. "Efficacy of mesenchymal stromal cells in preclinical models of necrotizing enterocolitis: a systematic review protocol." F1000Research 10 (October 5, 2021): 1011. http://dx.doi.org/10.12688/f1000research.73094.1.
Full textDissertations / Theses on the topic "Necrotizing enterocolitis, infants, treatment"
Zani, A. "Investigation of novel therapeutic agents for the treatment of necrotizing enterocolitis." Thesis, University College London (University of London), 2013. http://discovery.ucl.ac.uk/1403225/.
Full textMeinzen-Derr, Jareen. "A prediction model for risk of necrotizing enterocolitis among very low birth weight infants /." Cincinnati, Ohio : University of Cincinnati, 2006. http://www.ohiolink.edu/etd/view.cgi?acc%5Fnum=ucin1148300527.
Full textMEINZEN-DERR, JAREEN. "A PREDICTION MODEL FOR RISK OF NECROTIZING ENTEROCOLITIS AMONG VERY LOW BIRTH WEIGHT INFANTS." University of Cincinnati / OhioLINK, 2006. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1148300527.
Full textViswanathan, Sreekanth K. "STANDARDIZED SLOW ENTERAL FEEDING PROTOCOL AND INCIDENCE OF NECROTIZING ENTEROCOLITIS IN EXTREMELY LOW BIRTH WEIGHT INFANTS." Case Western Reserve University School of Graduate Studies / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=case1403738800.
Full textCohran, Valeria C. "Necrotizing Enterocolitis and Its Impact on Neurodevelopmental Outcomes in 400-1000 Gram Infants: A Population Based Study." Cincinnati, Ohio : University of Cincinnati, 2004. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=1092366453.
Full textCarter, Brigit Maria Holditch-Davis Diane. "Identification of risk factors for necrotizing enterocolitis in preterm infants how race, gender, and maternal health status contribute /." Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2009. http://dc.lib.unc.edu/u?/etd,2863.
Full textTitle from electronic title page (viewed Jun. 4, 2010). "... in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the School of Nursing." Discipline: Nursing; Department/School: Nursing.
Van, Niekerk Evette. "The use of probiotics in the management of necrotising enterocolitis in HIV exposed premature and very-low birth weight infants." Thesis, Stellenbosch : Stellenbosch University, 2014. http://hdl.handle.net/10019.1/96020.
Full textENGLISH ABSTRACT: Introduction: An association between maternal human immunodeficiency virus (HIV) infection and Necrotizing Enterocolitis (NEC) in preterm infants has been reported. The impact of probiotics in an HIV-exposed very low birth weight (VLBW) infant on the occurrence of NEC is uncertain at present; however it is known that probiotics have protective effects against inflammation and prevent NEC. Postnatal growth restriction is a major issue in preterm, especially extremely-low-birth-weight (ELBW) infants and probiotics have been found to improve feeding tolerance in preterm infants. Human milk oligosaccharides (HMO) also known as the prebiotics of human milk, are known to have bifidogenic and anti-adhesive effects. Infants that receive human milk show a reduced incidence of NEC compared to those who receive infant formula. Very little is known about the composition of breast milk in the HIV-infected mother. Objective: The primary objective of the study was to assess the effect of probiotics on the incidence and severity of NEC in high-risk infants born to HIV-positive and HIV-negative women. The secondary objectives were to assess the effect of probiotic administration on feeding tolerance and growth outcomes of HIV-exposed but uninfected preterm infants, to describe the HMO composition of HIV-infected mothers breast milk and lastly to determine if HMO composition affects the incidence of NEC in HIV-exposed preterm very low birth weight infants. Patients and Methods: A randomized, double blind, placebo controlled trial was conducted for the period July 2011 to August 2012. HIV-exposed and HIV-unexposed premature (<34 weeks gestation) infants with a birth weight of ≥500g and ≤1250g were randomized to receive either a probiotic or a placebo. The probiotic consisted of 1x109 CFU, L. rhamnosus GG and B. infantis per day and was administered for 28 days. NEC was graded according to Bell’s criteria. Anthropometrical parameters and daily intakes were monitored. Breats milk samples were analysed for oligosaccharide content. Results: 74 HIV-exposed and 110 HIV-unexposed infants were enrolled and randomized (mean birth-weight, 987g; mean gestational 28.7 weeks). The incidence of death and NEC did not differ significantly between the HIV-exposed and unexposed groups but a significantly higher NEC incidence was found in the control group. There was no difference in the average daily weight gain for treatment groups or HIV exposure. The HIV-exposed group achieved significantly higher z-scores for length and head circumference at day 28 than the unexposed group (p<0.01 and p=0.03, respectively). There were no differences in the incidence of any signs of feeding intolerance and abdominal distension between the groups. Our results show significantly higher absolute concentrations of 2’-fucosyllactose, laco-N-tetraose and lacto-N-fucopentaose 1 and higher relative abundance of 3’-sialyllactose, difucosyl-lacto-N-tetraose and fucosyl-disialyllacto-N-hexaose in HIV-infected compared to -uninfected Secretor women. DSLNT concentrations were significantly lower in the breast milk of mothers whose infants developed NEC compared to infants without NEC. Conclusion: Probiotic supplementation reduced the incidence of NEC in the premature infants; however results failed to show a lower incidence of NEC in HIV-exposed premature infants. Probiotic supplementation did not affect growth outcomes or the incidence of any signs of feeding intolerance in HIV-exposure. The data confirms previous reports that HIV-infected mothers have higher 3’sialyllactose milk concentrations. Most intriguing though, the data also indicates that low levels of DSLNT in the mother’s milk increase the infant’s risk for NEC, which is in accordance with results from previously published animal studies and warrants further investigation.
AFRIKAANSE OPSOMMING: Inleiding: ʼn Verwantskap tussen moederlike menslike immuniteitsgebreksvirus (MIV) en nekrotiserende enterokolitis (NEK) in premature babas is aangemeld. Die impak van probiotika in ʼn MIV-blootgestelde baie lae geboortemassa (BLGM) baba op die voorkoms van NEK is tans nog onseker, maar dit is wel bekend dat probiotika ʼn beskermende effek het teen inflammasie en die voorkoms van NEK. Nageboortelike groei beperkings is ʼn groot probleem in premature, veral ekstreme lae geboortemassa (ELGM) babas. Daar is gevind dat probiotika voeding toleransie in premature babas kan verbeter. Menslike melk oligosakkariede (MMO), ook bekend as die prebiotika van menslike melk, is bekend om bifidogeniese en anti-kleef effekte te hê. Babas wat moedersmelk ontvang toon ʼn verlaagde voorkoms van NEK in vergelyking met diegene wat baba formule melk ontvang. Baie min inligting is bekend oor die samestelling van borsmelk in die MIV-positiewe moeder. Doel: Die primêre doel van die studie was om die effek van probiotika op die voorkoms en die graad van NEK in hoë risiko babas van MIV-positiewe en MIV-negatiewe vroue te bepaal. Die sekondêre doelwitte was om die effek van probiotika op voeding verdraagsaamheid en groei uitkomste van MIV-blootgestelde, maar nie- geinfekteerde premature babas te evalueer sowel as die MMO samestelling van MIV-positiewe moeders se borsmelk te beskryf en laastens om die invloed van die MMO samestelling op die voorkoms van NEK in baie lae geboortegewig MIV-blootgestelde premature babas te beskryf. Pasiënte en Metodes: ʼn Gerandomiseerde, dubbelblinde, plasebo-beheerde studie is vir die tydperk Julie 2011 tot Augustus 2012 onderneem. MIV-blootgestelde en nie-blootgestelde premature (<34 weke) babas met 'n geboorte gewig van ≥500g en ≤1250g was ewekansig verdeel om probiotika of plasebo te ontvang. Die probiotika het bestaan uit 1x109 kolonie vormende eenhede, L. rhamnosus GG en B. infantis per dag en is toegedien vir 28 dae. NEK is gegradeer volgens Bell se kriteria. Antropometriese parameters en daaglikse inname is gemonitor. Borsmelk monsters is geanaliseer vir oligosakkaried inhoud. Resultate: 74 MIV-blootgestelde en 110 MIV-nie-blootgestelde babas is ingesluit en ewekansig ingedeel (gemiddelde geboorte gewig, 987g, gemiddelde gestasie 28,7 weke). Die voorkoms van die sterftes en NEK het nie beduidend verskil tussen die MIV-blootgestelde en nie-blootgestelde groepe nie, maar 'n beduidende verskil is gevind vir NEK voorkoms tussen die studie en die kontrole groep. Daar was geen verskil in die gemiddelde daaglikse gewigstoename tussen die behandelings groepe of MIV-blootstelling nie. Die MIV-blootgestelde groep het beduidend hoër z-tellings vir lengte en kopomtrek op dag 28 getoon teenoor die nie-blootgestelde groep (p <0.01 en p = 0,03, onderskeidelik). Daar was geen verskille in die voorkoms van voeding onverdraagsaamheid en abdominale distensie tussen die twee groepe nie. Ons resultate dui op aansienlik hoër absolute konsentrasies van 2'-fucosyllactose, laco-N-tetraose en lakto-N-fucopentaose 1 en hoër relatiewe voorkoms van 3'-sialyllactose, difucosyl-lakto-N-tetraose en fucosyl-disialyllacto-N-hexaose in MIV-positiewe vroue in vergelyking met-negatiewe Sekretor vroue. DSLNT konsentrasies was aansienlik laer in die melk van moeders wie se babas NEK ontwikkel het in vergelyking met babas sonder NEK. Gevolgtrekking: Probiotika aanvullings verminder die voorkoms van NEK in premature babas, maar die resultate kon nie ʼn laer voorkoms van NEK in MIV-blootgestelde premature babas bewys nie. Probiotiese aanvulling het geen invloed op groei uitkomste of die voorkoms van voeding onverdraagsaamheid in MIV-blootstelling getoon nie. Die data bevestig vorige verslae wat aandui dat MIV-besmette moeders hoër 3'sialyllactose borsmelk konsentrasies het. ʼn Interessante aspek is dat lae vlakke van DSLNT in die moeder se melk beduidend is van ʼn verhoogde risiko vir NEK, wat in ooreenstemming is met die resultate uit voorheen gepubliseerde dier studies en regverdig verdere ondersoeke.
Spaargaren, Elizabeth. "Clinical characteristics and prevalence of necrotizing enterocolitis among infants with dysphagia using SimplyThick." Thesis, 2017. https://hdl.handle.net/2144/23722.
Full text2019-07-11T00:00:00Z
Chowdhury, Allison. "The benefits of donor human breastmilk in preterm infants." Thesis, 2020. https://hdl.handle.net/2144/41200.
Full text"Necrotizing enterocolitis versus spontaneous intestinal perforation in high risk neonates: comparative investigations of plasma profiles of immunoregulatory proteins and specific expressions in intestinal tissues." 2011. http://library.cuhk.edu.hk/record=b5894836.
Full textThesis (M.Phil.)--Chinese University of Hong Kong, 2011.
Includes bibliographical references (leaves 179-204).
Abstracts in English and Chinese.
Abstract --- p.i
中文摘要 --- p.v
Acknowledgement --- p.viii
List of Abbreviations and Symbols x --- p.vi
List of Tables --- p.xx
List of Figures --- p.xxi
Chapter CHAPTER ONE --- Introduction --- p.1
Chapter 1.1 --- General Overview --- p.1
Chapter 1.2 --- Necrotizing Enterocolitis (NEC) --- p.3
Chapter 1.2.1 --- Epidemiology of NEC --- p.3
Chapter 1.2.2 --- "Clinical Presentation, Diagnosis and Management of NEC" --- p.5
Chapter 1.2.3 --- Pathophysiology of NEC --- p.9
Chapter 1.2.3.1 --- Prematurity --- p.9
Chapter 1.2.3.2 --- Bacterial Colonization --- p.12
Chapter 1.2.3.3 --- Enteral Feeding --- p.15
Chapter 1.2.3.4 --- Hypoxia and Ischemia --- p.16
Chapter 1.2.3.5 --- Genetic Polymorphism --- p.17
Chapter 1.2.3.6 --- Inflammatory Mediators --- p.20
Chapter 1.3 --- Spontaneous Intestinal Perforation (SIP) --- p.24
Chapter 1.3.1 --- Epidemiology of SIP --- p.24
Chapter 1.3.2 --- "Clinical Presentation, Diagnosis and Management of SIP" --- p.26
Chapter 1.3.3 --- Risk Factors of SIP --- p.28
Chapter 1.3.3.1 --- Prematurity --- p.29
Chapter 1.3.3.2 --- Use of Drugs --- p.30
Chapter 1.4 --- Comparison between NEC and SIP --- p.32
Chapter 1.5 --- Role of Cytokines in Pathogenesis of NEC and SIP --- p.38
Chapter 1.6 --- Immunoregulatory Molecules of Interest in This Study --- p.46
Chapter 1.6.1 --- Angiopoietin-2 (Ang-2) --- p.46
Chapter 1.6.2 --- v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2 (avian) (ErbB3) --- p.48
Chapter 1.6.3 --- Type II Interleukin-1 Receptor (IL-1RII) --- p.52
Chapter 1.6.4 --- Urokinase Plasminogen Activator Receptor (uPAR) --- p.54
Chapter CHAPTER TWO --- Objectives --- p.57
Chapter CHAPTER THREE --- Materials and Methodology --- p.58
Chapter 3.1 --- Overview of the Experimental Procedures --- p.58
Chapter 3.1.1 --- Investigation on the Profile of Circulatory Immunoregulatory Proteins in Plasma of NEC and SIP High Risk Neonates --- p.58
Chapter 3.1.2 --- Investigation on the mRNA Expression Level of Targeted Immunoregulatory Molecules on Resected Intestinal Tissues in NEC and SIP Neonates --- p.58
Chapter 3.1.3 --- Investigation on the mRNA and Protein Expression Levels of Targeted Immunoregulatory Molecules in Human Intestinal Cell Lines --- p.60
Chapter 3.2 --- Reagents and Lab-wares with Their Sources --- p.61
Chapter 3.3 --- Study Population --- p.63
Chapter 3.4 --- Collection of Neonatal Whole Blood Samples --- p.65
Chapter 3.5 --- Cytokine Antibody Array Analyses --- p.67
Chapter 3.6 --- Enzyme-linked Immunosorbant Assays (ELISA) --- p.69
Chapter 3.6.1 --- Angiopoietin-2 --- p.69
Chapter 3.6.2 --- sErbB3 --- p.71
Chapter 3.6.3 --- sIL-lRII --- p.72
Chapter 3.6.4 --- suPAR --- p.74
Chapter 3.7 --- Collection of Neonatal Resected Intestinal Tissues --- p.76
Chapter 3.8 --- Resected Intestinal Tissue RNA Isolation --- p.78
Chapter 3.9 --- Purity Assessment of the Purified Tissue RNA Samples --- p.80
Chapter 3.10 --- Integrity Assessment of the Purified Tissue RNA Samples --- p.81
Chapter 3.11 --- In vitro Stimulation of Human Enterocytes by Lipopolysaccharides (LPS) and/or Platelet Activating Factor (PAF) --- p.84
Chapter 3.12 --- mRNA Expression Level Assessment of Selected Target Genes in Resected Intestinal Tissues and Human Intestinal Cell Lines --- p.86
Chapter 3.12.1 --- Synthesis of First Strand cDNA --- p.86
Chapter 3.12.2 --- Quantitative Polymerase Chain Reaction (qPCR) --- p.87
Chapter 3.13 --- Statistical Analysis --- p.89
Chapter CHAPTER FOUR --- Screening of Immunoregulatory Target Protein Molecules in Plasma of NEC and SIP Patients by Cytokine Array Analyses --- p.104
Chapter 4.1 --- Results --- p.104
Chapter 4.1.1 --- Screening of Detectable Immunoregulatory Target Molecules --- p.104
Chapter 4.1.2 --- Selection of Target Molecules Based on the Fold Change in NEC or SIP Compared with Control Samples --- p.105
Chapter 4.1.2.1 --- Similar Regulation of Target Molecules in Both NEC and SIP patients --- p.105
Chapter 4.1.2.2 --- Differential regulation of Target Molecules in NEC and SIP Patients --- p.106
Chapter 4.1.2.3 --- "Relative Normalized Expressions of Selected Circulatory Immunoregulatory Protein Molecules in NEC, SIP and Control Neonates" --- p.108
Chapter 4.1.2.3.1 --- Anti-inflammation --- p.108
Chapter 4.1.2.3.2 --- Pro-inflammation --- p.109
Chapter 4.1.2.3.3 --- Cell Growth --- p.110
Chapter 4.1.2.3.4 --- Wound Healing --- p.110
Chapter 4.1.2.3.5 --- Angiogenesis --- p.111
Chapter 4.1.2.3.6 --- "Anti-apoptosis, Cell Adhesion and Extracellular Matrix Organization" --- p.112
Chapter 4.1.3 --- Further Selection of Novel Target Molecules Based on Statistical Significance and Fold Change of NEC versus SIP --- p.113
Chapter 4.2 --- Discussion --- p.115
Chapter CHAPTER FIVE --- Validation of Target Proteins in Plasma of NEC and SIP Patients by Enzyme-linked Immunosorbant Assay --- p.132
Chapter 5.1 --- Results --- p.133
Chapter 5.1.1 --- Demographic Data of the Study Group --- p.133
Chapter 5.1.2 --- "Comparison of Plasma Levels of Target Proteins between NEC, SIP and Respective Controls" --- p.134
Chapter 5.1.3 --- Longitudinal Study of the Pre- and Post-operative Target Proteins Levels in Plasma --- p.136
Chapter 5.2 --- Discussion --- p.138
Chapter CHAPTER SIX --- Investigation on mRNA Expression Levels of Target Immunoregulatory Protein Molecules in Intestinal Tissue and Intestinal Cell Lines --- p.151
Chapter 6.1 --- Results --- p.152
Chapter 6.1.1 --- mRNA Expression Levels of Target Molecules in the Diseased Margin of Resected Intestinal Tissues of NEC and SIP patients --- p.152
Chapter 6.1.2 --- mRNA Expression Levels of Target Molecules in the Macroscopically Normal and Diseased Margin of Resected Intestinal Tissues of NEC and SIP patients --- p.154
Chapter 6.1.3 --- mRNA Expression Levels of Target Molecules in Human Intestinal Cell Lines upon LPS and PAF Challenge --- p.156
Chapter 6.1.3.1 --- FHs-74 Int Cell Line --- p.156
Chapter 6.1.3.2 --- Caco-2 Cell Line --- p.157
Chapter 6.2 --- Discussion --- p.158
Chapter CHAPTER SEVEN --- General Discussion --- p.171
Chapter 7.1 --- Overall Findings --- p.171
Chapter 7.2 --- Limitations of Study --- p.174
Chapter 7.3 --- Future Investigations --- p.177
References --- p.179
Books on the topic "Necrotizing enterocolitis, infants, treatment"
F, Gilchrist Brian, ed. Necrotizing enterocolitis. Georgetown, Tex: Eurekah.com, 2000.
Find full textStirt, Joseph A. Baby. Far Hills, N.J: New Horizon Press, 1992.
Find full textHackam, David J. Necrotizing Enterocolitis: Pathogenesis, Diagnosis and Treatment. Taylor & Francis Group, 2020.
Find full textHackam, David J. Necrotizing Enterocolitis: Pathogenesis, Diagnosis and Treatment. Taylor & Francis Group, 2020.
Find full textHackam, David J. Necrotizing Enterocolitis: Pathogenesis, Diagnosis and Treatment. Taylor & Francis Group, 2021.
Find full textHackam, David J. Necrotizing Enterocolitis: Pathogenesis, Diagnosis and Treatment. Taylor & Francis Group, 2020.
Find full textHackam, David J. Necrotizing Enterocolitis: Pathogenesis, Diagnosis and Treatment. Taylor & Francis Group, 2020.
Find full textHylton, Jared, and Sarah Deverman. Necrotizing Enterocolitis. Edited by Kirk Lalwani, Ira Todd Cohen, Ellen Y. Choi, and Vidya T. Raman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190685157.003.0001.
Full textHackam, David J. Necrotizing Enterocolitis: Insights into Pathogenesis, Diagnosis and Treatment. World Scientific Publishing Co Pte Ltd, 2017.
Find full textViscardi, Rose M., and Ken B. Waites. Ureaplasma urealyticum and Ureaplasma parvum. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0022.
Full textBook chapters on the topic "Necrotizing enterocolitis, infants, treatment"
Neu, Josef. "Necrotizing Enterocolitis." In Nutritional Care of Preterm Infants, 253–63. Basel: S. KARGER AG, 2014. http://dx.doi.org/10.1159/000358474.
Full textShelby, Rita D., Terrence M. Rager, Barrett P. Cromeens, and Gail E. Besner. "The Role of Growth Factor Signaling in the Development and Treatment of Necrotizing Enterocolitis." In Necrotizing Enterocolitis, 164–72. First edition. | Boca Raton : CRC Press, 2020.: CRC Press, 2021. http://dx.doi.org/10.1201/9780429288302-32.
Full textHall, Nigel J., and Agostino Pierro. "Surgical Treatment of Necrotizing Enterocolitis." In Neonatology, 731–34. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-1405-3_97.
Full textHall, Nigel J., and Agostino Pierro. "Surgical Treatment in Newborns of Necrotizing Enterocolitis." In Neonatology, 1–7. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-18159-2_236-1.
Full textHall, Nigel J., and Agostino Pierro. "Surgical Treatment in Newborns of Necrotizing Enterocolitis." In Neonatology, 1395–401. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-29489-6_236.
Full textZani, Augusto, Mara Cananzi, Simon Eaton, and Paolo De Coppi. "Treatment of Necrotizing Enterocolitis (NEC) with Amniotic Fluid Stem Cells." In Perinatal Stem Cells, 27–42. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1118-9_3.
Full textDuffy, Linda C., Maria A. Zielezny, Vivien Carrion, Elizabeth Griffiths, Diane Dryja, Milo Hilty, James Cummings, and Frederick Morin. "Bacterial Toxins and Enteral Feeding of Premature Infants at Risk for Necrotizing Enterocolitis." In Advances in Experimental Medicine and Biology, 519–27. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1371-1_64.
Full textAbdallah, Claude, and Anthony Sandler. "Perioperative Anesthetic Considerations in the Management of Necrotizing Enterocolitis (NEC) in Newborns and Short Bowel Syndrome (SBS) in Infants." In Anesthetic Management in Pediatric General Surgery, 237–48. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-72551-8_16.
Full textAbdallah, Claude, and Anthony Sandler. "Perioperative Anesthetic Considerations in the Management of Necrotizing Enterocolitis (NEC) in Newborns and Short Bowel Syndrome (SBS) in Infants." In Anesthetic Management in Pediatric General Surgery, 237–48. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-72551-8_16.
Full textde la Cruz, Diomel, Allison Lure, and Josef Neu. "Necrotizing Enterocolitis." In Nutritional Care of Preterm Infants, 367–78. S. Karger AG, 2021. http://dx.doi.org/10.1159/000514760.
Full textConference papers on the topic "Necrotizing enterocolitis, infants, treatment"
Tomislav, Ćaleta, Vukšić Iva, Živković Petra, Benjak Vesna, Dasović Buljević Andrea, Ninković Dorotea, Filipović-Grčić Boris, et al. "136 Short-term outcomes for preterm infants with surgical necrotizing enterocolitis." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.136.
Full textMar, Pamela K., Jeffrey Galley, Adrian Rajab, and Gail E. Besner. "Urine Extracellular Vesicle-derived miRNA Patterns in Infants with Necrotizing Enterocolitis." In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.923.
Full textZhao, Ji-Xue, Chuan Zhang, Xue-Song Zhao, Chun-Yu Dong, and Xin Fu. "The Application of Early Ostomy Closure on the Infants with Necrotizing Enterocolitis." In 2015 International Conference on Medicine and Biopharmaceutical. WORLD SCIENTIFIC, 2016. http://dx.doi.org/10.1142/9789814719810_0012.
Full textMueller, Martina, Sarah N. Taylor, Carol L. Wagner, and Jonas S. Almeida. "Using an artificial neural network to predict necrotizing enterocolitis in premature infants." In 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta). IEEE, 2009. http://dx.doi.org/10.1109/ijcnn.2009.5178635.
Full textZhao, Ji-Xue, Chuan Zhang, Xue-Song Zhao, Chun-Yu Dong, and Xin Fu. "The application of early ostomy closure on the infants with necrotizing enterocolitis." In 2016 5th International Conference on Sustainable Energy and Environment Engineering (ICSEEE 2016). Paris, France: Atlantis Press, 2016. http://dx.doi.org/10.2991/icseee-16.2016.131.
Full textHooven, Thomas, Yun Chao Lin, and Ansaf Salleb-Aouissi. "Multiple instance learning for predicting necrotizing enterocolitis in premature infants using microbiome data." In ACM CHIL '20: ACM Conference on Health, Inference, and Learning. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3368555.3384466.
Full textAvula, Sravani, Leanne Nantais-Smith, Ranjan Monga, Lizbeth Lockwood, and Mark Kadrofske. "Stool Biomarkers to Diagnose Necrotizing Enterocolitis in Preterm Infants: A Pilot Case-Control Study." In Selection of Abstracts From NCE 2015. American Academy of Pediatrics, 2017. http://dx.doi.org/10.1542/peds.140.1_meetingabstract.78.
Full textLaw, Jodi Woan-Fei, Vengadesh Letchumanan, Hooi-Leng Ser, Loh Teng-Hern Tan, Priyia Pusparajah, and Learn-Han Lee. "IDDF2021-ABS-0108 Enterobacteriaceae – deciphering the culprit gut bacteria causing necrotizing enterocolitis in infants." In Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 4–5 September 2021. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2021. http://dx.doi.org/10.1136/gutjnl-2021-iddf.39.
Full textKnell, Jamie, Sam M. Han, Erika M. Edwards, Kate A. Morrow, Roger F. Soll, Tom Jaksic, Jeffrey D. Horbar, and Biren P. Modi. "Impact of Necrotizing Enterocolitis On Outcomes In Very Low Birth Weight Infants With Neurologic Injury." In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.909.
Full textRolnitsky, Asaph, Eugene Ng, Yasmin Shama, Maren Garche, and Michael Dunn. "841 Routine supplementation of probiotics for prevention of necrotizing enterocolitis in premature infants—a qi project." In Institute for Healthcare Improvement (IHI) Scientific Symposium on Improving the Quality and Value of Health Care. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/bmjoq-2017-ihi.3.
Full textReports on the topic "Necrotizing enterocolitis, infants, treatment"
Zhou, Ke-Zhao, Li-Yan Zhang, Kang Wu, Lin-Xuan Deng, and Man Hu. Probiotics to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants: A Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0001.
Full text